Giaccardi Marzia, Nesti Martina, Segreti Luca, Rossi Andrea, Porcedda Giulio, Bongiorni Maria Grazia
Ospedale Santa Maria Annunziata, Bagno a Ripoli-Firenze.
Ospedale San Donato, Arezzo.
G Ital Cardiol (Rome). 2022 Jun;23(6):454-460. doi: 10.1714/3810.37942.
Leadless, intracardiac pacemakers are a major innovation in the management of bradyarrhythmia. Both safety and feasibility of leadless pacing have been assessed in acute settings and mid-term follow-up showing a significant reduction of pacing-related complications as compared with standard transvenous pacemakers. There are many advantages of the leadless approach including a reduction of infection risk and malfunction due to the absence of transvenous leads and the pacemaker pocket. Patients at high risk of endocarditis or pocket failure, with compromised venous access, can benefit from the leadless approach. In this review article, the relevant implant indications for leadless pacemaker and patient populations are described.
无导线心内起搏器是缓慢性心律失常治疗领域的一项重大创新。无导线起搏的安全性和可行性已在急性情况下及中期随访中得到评估，结果显示与标准经静脉起搏器相比，起搏相关并发症显著减少。无导线起搏方法有诸多优点，包括由于没有经静脉导线和起搏器囊袋，感染风险和故障减少。心内膜炎或囊袋故障高危、静脉通路受损的患者可从无导线起搏方法中获益。在这篇综述文章中，描述了无导线起搏器的相关植入适应症及患者群体。
